BioTelemetry (BEAT) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
BioTelemetry, Inc. Reports Third Quarter 2015 Financial Results
November 9, 2015 4:06 PM ESTMALVERN, Pa., Nov. 09, 2015 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2015.
Company Highlights
Achieved second consecutive quarter of profitability with $2.5 million GAAP net income  Experienced thirteenth consecutive quarter of year over year revenue growthGenerated positive adjusted EBITDA of $8.7 million, highest since 2008CMS issued final 2016 physician fee schedule with an increase of 8% for Mobile Cardiac... More


